Radiation reduces failure risk in newly diagnosed nonmetastatic prostate cancer

Routine use of radiation therapy appeared to prolong failure-free survival among patients with nonmetastatic, newly diagnosed prostate cancer regardless of nodal status, according to findings from the control arm of the STAMPEDE trial.

Healio